Rapidly progressive interstitial lung disease complicated by pulmonary interstitial emphysema in anti-MDA5 amyotrophic dermatomyositis

被引：0
|
作者：
Kenyon, Sarrinder [1 ]
Careless, David [2 ,3 ]
Navaratnam, Vidya [4 ,5 ]
Reddy, Taryn [1 ,6 ]
机构：
[1] Prince Charles Hosp, Dept Med Imaging, Chermside, Qld 4032, Australia
[2] St Andrews Ipswich Private Hosp, Dept Gen Med, Ipswich, Qld, Australia
[3] Ipswich Hosp, Dept Gen Med, Ipswich, Qld, Australia
[4] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia
[5] Curtin Univ, Div Hlth Sci, Perth, WA, Australia
[6] Univ Queensland, Fac Med, Herston, Qld, Australia
来源：
THORAX | 2023年
关键词：
Connective tissue disease associated lung disease;
D O I：
10.1136/thorax-2022-219859
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：946 / 947
页数：2
相关论文
共 50 条
  • [31] Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
    Sakamoto, Noriho
    Ishimoto, Hiroshi
    Nakashima, Shota
    Yura, Hirokazu
    Miyamura, Takuto
    Okuno, Daisuke
    Hara, Atsuko
    Kitazaki, Takeshi
    Kakugawa, Tomoyuki
    Ishimatsu, Yuji
    Satoh, Minoru
    Mukae, Hiroshi
    INTERNAL MEDICINE, 2019, 58 (06) : 837 - 841
  • [32] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    Ho So
    Victor Tak Lung Wong
    Virginia Weng Nga Lao
    Hin Ting Pang
    Ronald Man Lung Yip
    Clinical Rheumatology, 2018, 37 : 1983 - 1989
  • [33] Refractory cutaneous ulcers in anti-MDA5 dermatomyositis were not associated with rapidly progressive interstitial lung disease, and responded to tadalafil
    Ge, Yongpeng
    Jiang, Wei
    Lu, Xin
    Wang, Guochun
    Shu, Xiaoming
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 71
  • [34] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    So, Ho
    Wong, Victor Tak Lung
    Lao, Virginia Weng Nga
    Pang, Hin Ting
    Yip, Ronald Man Lung
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1983 - 1989
  • [35] Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
    Li, Xiaomeng
    Liu, Yongmei
    Cheng, Linlin
    Huang, Yuan
    Yan, Songxin
    Li, Haolong
    Zhan, Haoting
    Li, Yongzhe
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (11)
  • [36] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN SERONEGATIVE AMYOTROPHIC DERMATOMYOSITIS
    Asif, Muhammad Raza
    Malik, Shehryar
    Riaz, Khadeeja
    Abdulmajeed, Firas
    CHEST, 2024, 166 (04) : 3218A - 3219A
  • [37] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Huyan Wang
    Xin Chen
    Yan Du
    Lihua Wang
    Qiyuan Wang
    Huaxiang Wu
    Lei Liu
    Jing Xue
    Arthritis Research & Therapy, 25
  • [38] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Wang, Huyan
    Chen, Xin
    Du, Yan
    Wang, Lihua
    Wang, Qiyuan
    Wu, Huaxiang
    Liu, Lei
    Xue, Jing
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [39] Rapidly progressive interstitial lung disease associated with dermatomyositis-Longitudinal course of anti-MDA5 antibody titer in two cases
    Awaji, Kentaro
    Asano, Yoshihide
    Fukui, Yuki
    Oka, Tomonori
    Toyama, Tetsuo
    Sato, Shinichi
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (04) : 78 - 81
  • [40] A Fatal Case of Anti-MDA5 Antibody Positive Clinically Amyopathic Dermatomyositis (CADM) Associated with Rapidly Progressive Interstitial Lung Disease
    Mohammed, A.
    Torres, C.
    AlNabulsi, M.
    Smith, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345